3S KOREA Co., Ltd. (KOSDAQ:060310)
1,468.00
+13.00 (0.89%)
At close: Apr 16, 2026
3S KOREA Revenue
3S KOREA had revenue of 5.43B KRW in the quarter ending December 31, 2025, a decrease of -16.05%. This brings the company's revenue in the last twelve months to 31.97B, up 3.73% year-over-year. In the fiscal year ending March 31, 2025, 3S KOREA had annual revenue of 29.02B, down -33.43%.
Revenue (ttm)
31.97B
Revenue Growth
+3.73%
P/S Ratio
2.41
Revenue / Employee
326.21M
Employees
98
Market Cap
77.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 29.02B | -14.57B | -33.43% |
| Mar 31, 2024 | 43.60B | 1.74B | 4.15% |
| Mar 31, 2023 | 41.86B | 14.75B | 54.40% |
| Mar 31, 2022 | 27.11B | 3.63B | 15.47% |
| Mar 31, 2021 | 23.48B | 885.89M | 3.92% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Yooshin Engineering | 339.58B |
| RFTech | 266.01B |
| WiTS Co., Ltd. | 168.72B |
| Jeil M&S | 151.27B |
| Green Cross Medical Science | 108.41B |
| Icure Pharmaceutical Incorporation | 83.38B |
| Korea Business News | 75.91B |
| GL Pharm Tech | 35.27B |